American well chief accounting officer sells $8,489 in stock

Paul Francis McNeice, Chief Accounting Officer at American Well Corp (NASDAQ:AMWL), sold 653 shares of the company’s Class A Common Stock on October 1, 2026. The shares were sold at a price of $13.0 per share, totaling $8,489. The stock currently trades at $12.70, up 118% over the past year despite significant volatility. According to InvestingPro analysis, AMWL appears undervalued at current levels, placing it among opportunities on the Most Undervalued list.

The transaction was identified as a "sell to cover" to address tax liabilities that arose from the vesting and settlement of restricted stock units on the same date. This sale was an automatic transaction and did not represent a discretionary trade by Mr. McNeice.

Following this transaction, Mr. McNeice directly holds 9,086 shares of American Well Corp Class A Common Stock. For deeper insights into AMWL’s financial health and comprehensive analysis, investors can access the detailed Pro Research Report, available exclusively on InvestingPro alongside additional ProTips for this telehealth company.

In other recent news, American Well Corp., also known as Amwell, reported second-quarter 2026 results that surpassed Wall Street expectations in both earnings and revenue. The company announced an adjusted loss per share of $0.59, which was narrower than the anticipated $0.89 loss, while revenue reached $52.05 million, exceeding the $50.10 million forecast. Following this positive performance, Amwell raised its full-year outlook, indicating a more optimistic future for the company. Additionally, Truist Securities raised its price target for Amwell to $12.00 from $7.50, maintaining a Hold rating on the stock. Truist updated its revenue estimates for Amwell, projecting $203 million in FY26 and $207 million in FY27, slightly higher than previous estimates. These developments reflect an improved margin profile and more upbeat guidance from Amwell’s management. Investors reacted positively to the earnings beat and the revised outlook, as seen in after-hours trading. The company’s recent performance and analyst adjustments highlight ongoing interest and potential in the telehealth sector.